Prospective Evaluation of the Transparent, Elastomeric, Adaptable, Long-Lasting (TEAL) Respirator

N95 filtering facepiece respirators (FFR) and surgical masks are essential in reducing airborne disease transmission, particularly during the COVID-19 pandemic. However, currently available FFR's and masks have major limitations, including masking facial features, waste, and integrity after dec...

Full description

Bibliographic Details
Main Authors: Wentworth, Adam J (Author), Byrne, James D (Author), Orguc, Sirma (Author), Sands, Joanna (Author), Maji, Saurav (Author), Tov, Caitlynn (Author), Babaee, Sahab (Author), Boyce, Hannah (Author), Huang, Hen-Wei (Author), Chai, Peter (Author), Min, Seokkee (Author), Li, Canchen (Author), Chu, Jacqueline N. (Author), Som, Avik (Author), Becker, Sarah L (Author), Gala, Manish (Author), Chandrakasan, Anantha P (Author), Traverso, Carlo Giovanni (Author)
Other Authors: Massachusetts Institute of Technology. Microsystems Technology Laboratories (Contributor), Massachusetts Institute of Technology. Department of Mechanical Engineering (Contributor), Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor)
Format: Article
Language:English
Published: American Chemical Society (ACS), 2021-05-12T21:25:50Z.
Subjects:
Online Access:Get fulltext
LEADER 02823 am a22004213u 4500
001 130587
042 |a dc 
100 1 0 |a Wentworth, Adam J  |e author 
100 1 0 |a Massachusetts Institute of Technology. Microsystems Technology Laboratories  |e contributor 
100 1 0 |a Massachusetts Institute of Technology. Department of Mechanical Engineering  |e contributor 
100 1 0 |a Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science  |e contributor 
100 1 0 |a Koch Institute for Integrative Cancer Research at MIT  |e contributor 
700 1 0 |a Byrne, James D  |e author 
700 1 0 |a Orguc, Sirma  |e author 
700 1 0 |a Sands, Joanna  |e author 
700 1 0 |a Maji, Saurav  |e author 
700 1 0 |a Tov, Caitlynn  |e author 
700 1 0 |a Babaee, Sahab  |e author 
700 1 0 |a Boyce, Hannah  |e author 
700 1 0 |a Huang, Hen-Wei  |e author 
700 1 0 |a Chai, Peter  |e author 
700 1 0 |a Min, Seokkee  |e author 
700 1 0 |a Li, Canchen  |e author 
700 1 0 |a Chu, Jacqueline N.  |e author 
700 1 0 |a Som, Avik  |e author 
700 1 0 |a Becker, Sarah L  |e author 
700 1 0 |a Gala, Manish  |e author 
700 1 0 |a Chandrakasan, Anantha P  |e author 
700 1 0 |a Traverso, Carlo Giovanni  |e author 
245 0 0 |a Prospective Evaluation of the Transparent, Elastomeric, Adaptable, Long-Lasting (TEAL) Respirator 
260 |b American Chemical Society (ACS),   |c 2021-05-12T21:25:50Z. 
856 |z Get fulltext  |u https://hdl.handle.net/1721.1/130587 
520 |a N95 filtering facepiece respirators (FFR) and surgical masks are essential in reducing airborne disease transmission, particularly during the COVID-19 pandemic. However, currently available FFR's and masks have major limitations, including masking facial features, waste, and integrity after decontamination. In a multi-institutional trial, we evaluated a transparent, elastomeric, adaptable, long-lasting (TEAL) respirator to evaluate success of qualitative fit test with user experience and biometric evaluation of temperature, respiratory rate, and fit of respirator using a novel sensor. There was a 100% successful fit test among participants, with feedback demonstrating excellent or good fit (90% of participants), breathability (77.5%), and filter exchange (95%). Biometric testing demonstrated significant differences between exhalation and inhalation pressures among a poorly fitting respirator, well-fitting respirator, and the occlusion of one filter of the respirator. We have designed and evaluated a transparent elastomeric respirator and a novel biometric feedback system that could be implemented in the hospital setting. 
520 |a NIH(Grants K23DA044874, R44DA051106) 
520 |a NIH (Grants K23DA044874, R44DA051106, 5T32DK007191-4) 
546 |a en 
655 7 |a Article 
773 |t ACS Pharmacology and Translational Science